NEW YORK (GenomeWeb News) – Affymetrix has named Andrew Last to be company chief operation officer and David Weber as chief commercial officer, the company said in a US Securities and Exchange Commission filing this week.

Last previously was executive VP of the firm's Genetic Analysis business unit, and Weber formerly was executive VP of global commercial operations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

CNBC reports that half of academic researchers leave after about five years.